NCT00056004View on ClinicalTrials.gov

Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

March 31, 2009

Conditions
Head and Neck CancerLung Cancer
Interventions
DRUG

zileuton

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00056004 - Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | Biotech Hunter | Biotech Hunter